MSLN and neoplasm: Staining done 7 days post-T cell injection showed the tumors to be devoid of GFP+ CAR T cell infiltration in mice treated with MigR control and Meso-CAR T cells (Fig. 2h) which notably had no impact on either FAP+ stromal cell or Mesothelin+ tumor cells even by day 7 post-T cell administration.